乳腺癌、胎盘与妊娠
本文为叙述性综述,讨论妊娠期乳腺癌高恶性、激素受体阴性/HER2阳性或三阴性特征,以及妊娠和产后短暂增加乳腺癌风险、随后长期保护的现象。综述汇总免疫与激素改变,包括针对滋养层抗原的母体免疫、T细胞参与、胎盘因子(如kisspeptin)的直接抗肿瘤作用,以及雌激素、孕激素等对肿瘤生长的影响。
要点
- 妊娠期乳腺癌常呈高恶性、激素受体阴性/HER2阳性或三阴性。
- 妊娠及产后短暂增加乳腺癌风险,随后为长期保护期。
- 胎盘转移极罕见,胎儿隔室乳腺癌转移尚无报道。
核心结论
- 多种因素和细胞参与妊娠期间及产后乳腺癌风险的改变,并具有未来开发新治疗策略的潜力。
研究设计与样本
- 叙述性综述,检索并汇总妊娠相关免疫与激素改变影响乳腺癌风险、肿瘤生长和行为的文献。
主要发现
- 经产妇中观察到参与免疫和生殖过程的乳腺癌相关基因上调,可能解释妊娠期短暂风险增加。
- 针对滋养层细胞表达抗原(如黏蛋白-1特定糖基化模式或RCAS1相关截短聚糖)的母体免疫和免疫球蛋白产生,似乎预防后期乳腺癌发生。
- 动物和人类研究提示T细胞参与上述过程。
- 多种胎盘来源因子,尤其是kisspeptin,具有直接抗肿瘤效应。
- 妊娠相关的雌激素、孕激素及其他激素增加影响乳腺癌生长和特征,其他胎盘分泌因子的作用仍有争议。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Breast cancer is one of the most frequently diagnosed malignancies during pregnancy. Tumours often present characteristics of high malignancy and are hormone receptor negative/HER2 positive or triple negative. In general, pregnancy, including the postpartum period, is associated with a transiently increased risk of developing breast cancer but followed by a long-lasting protective period. Placental metastases are very rare and, thus far, breast cancer metastases in the foetal compartment have not been described. To discuss these apparently contradictory observations, this narrative review resumes immunological and hormonal alterations during pregnancy potentially affecting breast cancer risk as well as tumour growth and behaviour. OBSERVATIONS: Upregulation of breast cancer-associated genes involved in immunological and reproductive processes has been observed in parous women and is potentially responsible for a transiently increased risk in pregnancy. In contrast, maternal immunisation and immunoglobulin production against antigens expressed on trophoblast cells, such as specific glycosylation patterns of mucin-1 or RCAS1-associated truncated glycans, seem to prevent breast cancer development in later years. Animal and human studies indicate that T cells are involved in these processes. Several placenta-derived factors, especially kisspeptin, have direct anti-tumour effects. The pregnancy-related increase of estrogen, progesterone, and other hormones influence growth and characteristics of breast cancer while the role of further placenta-secreted factors is still controversially discussed. CONCLUSION: Several factors and cells are involved in altered breast cancer risk during and after pregnancy and have potential for developing novel treatment strategies in future.
引用
- Froehlich K, Schmidt A, Heger JI, et al. Breast cancer, placenta and pregnancy. Eur J Cancer. 2019. PMID: 31121525. doi:10.1016/j.ejca.2019.03.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。